NALMEFEN-HYDROCHLORID-DIHYDRAT

European patent · EP2300479 · In force

Register entry

Publication number
EP2300479
Application number
EP09771286
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 4, 2009
Published
Mar 30, 2011
Granted
Feb 22, 2012
Protection ends at the latest
Dec 3, 2029
Next annual fee due
Dec 31, 2026
IPC classes
C07D 489/08 (2006.01)
A61K 31/485 (2006.01)
A61P 25/30 (2006.01)
Priority
DK 200801729 05.12.2008
US 120132 P 05.12.2008
PCT application
PCT/DK2009/050320 04.12.2009
PCT publication
WO2010/063292 10.06.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Feb 22, 2012

    Granted

    Published in Swissreg on 22.02.2012

Parties

Holder

H. Lundbeck A/S

Ottiliavej 9, 2500 Valby, DK

Biotie Therapies Corp.

Tykistökatu 6, 20520 Turku, FI

Inventor

LOPEZ DE DIEGO, Heidi

DK-2850 Nærum, DK

DE FAVERI, Carla

I-31010 Farra di Soligo, IT

HUBER, Florian Anton Martin

I-36050 Bolzano Vicentino, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.